Premium
Entrada Therapeutics Inc (TRDA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | Institution | 5 072 730 | 14,08% | US$ 33,38M | 2026-03-31 |
| Baker Brothers Life Sciences, L.P. | Institution | 4 691 392 | 13,02% | US$ 30,87M | 2025-11-20 |
| 5AM Venture Management, LLC | Institution | 4 056 379 | 11,26% | US$ 26,69M | 2026-03-31 |
| 5AM Ventures V, L.P. | Institution | 2 963 066 | 8,22% | US$ 19,50M | 2025-11-14 |
| Roche Holding AG | Institution | 2 569 115 | 7,13% | US$ 16,90M | 2024-12-31 |
| BlackRock, Inc. | Institution | 2 358 793 | 6,55% | US$ 15,52M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 2 287 500 | 6,35% | US$ 15,05M | 2026-03-31 |
| MPM Bioventures 2018, L.P. | Institution | 2 150 236 | 5,97% | US$ 14,15M | 2024-12-11 |
| MPM Bioventures 2014, L.P. | Institution | 2 122 055 | 5,89% | US$ 13,96M | 2024-12-11 |
| The Column Group, LLC | Institution | 1 917 344 | 5,32% | US$ 12,62M | 2025-11-19 |
| TCG Crossover Fund I, L.P. | Institution | 1 917 344 | 5,32% | US$ 12,62M | 2025-11-19 |
| Janus Henderson Biotech Innovation Master Fund Limited | Institution | 1 884 826 | 5,23% | US$ 12,40M | 2025-03-31 |
| MRL Ventures Fund LLC | Institution | 1 739 768 | 4,83% | US$ 11,45M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 256 013 | 3,49% | US$ 8,26M | 2026-03-31 |
| 5AM Opportunities I, L.P. | Institution | 1 093 313 | 3,03% | US$ 7,19M | 2025-11-14 |
| Wellington Management Group LLP | Institution | 1 034 782 | 2,87% | US$ 6,81M | 2026-03-31 |
| StepStone Group Inc. | Institution | 761 277 | 2,11% | US$ 5,01M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 667 347 | 1,85% | US$ 4,39M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 533 798 | 1,48% | US$ 3,51M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 526 043 | 1,46% | US$ 3,46M | 2026-03-31 |
| Millennium Management LLC | Institution | 519 356 | 1,44% | US$ 3,42M | 2026-03-31 |
| 667, L.P. | Institution | 381 338 | 1,06% | US$ 2,51M | 2025-11-20 |
| Jones Hill Capital LP | Institution | 374 010 | 1,04% | US$ 2,46M | 2026-03-31 |
| Jacobs Levy Equity Management Inc | Institution | 333 914 | 0,93% | US$ 2,20M | 2026-03-31 |
| Acadian Asset Management LLC | Institution | 333 169 | 0,92% | US$ 2,19M | 2026-03-31 |
| Dimensional Fund Advisors LP | Institution | 324 471 | 0,90% | US$ 2,14M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 234 992 | 0,65% | US$ 1,55M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 220 494 | 0,61% | US$ 1,45M | 2026-03-31 |
| Woodline Partners LP | Institution | 215 977 | 0,60% | US$ 1,42M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 215 018 | 0,60% | US$ 1,41M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 214 751 | 0,60% | US$ 1,41M | 2026-03-31 |
| Lynx1 Capital Management LP | Institution | 211 689 | 0,59% | US$ 1,39M | 2026-03-31 |
| Mr. Dipal Doshi | Initiés | 206 096 | 0,57% | US$ 1,36M | 2026-04-13 |
| Longaeva Partners L.P. | Institution | 204 978 | 0,57% | US$ 1,35M | 2026-03-31 |
| Renaissance Technologies LLC | Institution | 202 084 | 0,56% | US$ 1,33M | 2026-03-31 |
| Mr. Nathan Dowden | Initiés | 198 588 | 0,55% | US$ 1,31M | 2026-05-04 |
| BNP Paribas Financial Markets SNC | Institution | 181 148 | 0,50% | US$ 1,19M | 2026-03-31 |
| Teachers Insurance and Annuity Association-College Retirement Equities Fund | Institution | 174 118 | 0,48% | US$ 1,15M | 2026-03-31 |
| Nantahala Capital Management, LLC | Institution | 159 332 | 0,44% | US$ 1,05M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 156 861 | 0,44% | US$ 1,03M | 2026-03-31 |
| XTX Markets Limited | Institution | 129 562 | 0,36% | US$ 852,52k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
